Hopper’s Last Ride not Easy

Actor Dennis Hopper has died. The veteran actor, known for his icon role in Easy Rider as well as memorable roles in Blue Velvet, Hoosiers, and Speed, died of complications of prostate cancer. In November 2009 we reported on Hopper’s acknowledgment that he was fighting prostate cancer, and that it was a disease for which he was being treated during the previous nine years. Hopper revealed that he was being treated in an experimental program at University of Southern California.

Details of what kind of treatment he received were not released.

On March 18, 2010, it was announced that Hopper would be honored with the 2,403rd star on the Hollywood Walk of Fame, in front of the iconic Grauman’s Chinese Theater on Hollywood Boulevard.[39] Surrounded by friends including Jack Nicholson, Viggo Mortensen, David Lynch, Michael Madsen, family, and fans, he attended its addition to the sidewalk on March 26, 2010. In recent months it was reported that Hopper’s cancer had spread to his bones, and that he was too ill to come to court for a deposition in his pending divorce case.

For other stories we have done on various aspects of prostate cancer, see:

General David Petraeus Treated for Prostate Cancer : Prostate cancer basics

Dennis Hopper Goes to Breeder’s Cup, Despite Prostate Cancer : Risk factors and clinical trials

Andrew Lloyd Webber Diagnosed with Cancer: PSA testing

Louis Gossett Jr. Diagnosed with Prostate Cancer : Prostate cancer in African-Americans

For more information:

Resounding
Health(tm)
Prostate Cancer
Mark Boguski, M.D., Ph.D. is on the faculty of Harvard Medical School and is a member of the Society for Participatory Medicine, "a movement in which networked patients shift from being mere passengers to responsible drivers of their health" and in which professional health care providers encourage "empowered patients" and value them as full partners in managing their health and wellness.

Leave a Reply

Your email address will not be published.

Real Time Analytics Google Analytics Alternative